Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Postmarketing Safety Data - Cervarix, October 9, 2007

Gemignani, Helen S
From: Sullivan, Helen M
Sent: Tuesday, October 09, 2007 2:24 PM
To: ''
Cc: ''
Subject: RE: clarification
Your proposals and responses are acceptable to CBER.
From: []
Sent: Friday, October 05, 2007 6:22 PM
To: Sullivan, Helen M
Subject: clarification
STN 125259/0
Dear Helen:
My team has asked for clarification regarding the FAX of October 2, 2007. I'm attaching a clarifying note back to your
team. Please let us know if our interpretation and/or proposal is acceptable.
Thanks and regards,
Director, Adult Vaccines
(610) 787-3763
(internal: 8-275-3763)
"EMF <>" made the following annotations.
This message was sent by GlaxoSmith Kline across the Internet in encrypted format and was s

Page Last Updated: 04/09/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English